Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank67
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-39.72M
↑ 41% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-67.28M
Historical baseline
PeriodValueYoY Change
TTM$-39.72M+43.4%
2024$-70.13M+48.1%
2023$-135.01M-24.4%
2022$-108.50M-46.7%
2021$-73.96M-106.1%
2020$-35.88M-363.6%
2019$-7.74M-